Author

Audrey Page

Lyon 1 UniversitéORCID 0000-0002-2838-5892Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Research Focus:cell type annotation· 2 Organism:human· 2 Approach:statistical model· 2 Research Focus:cell-cell communication· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Assay:imaging· 1

Frequent Co-Authors

Jenny Valladeau‐GuilemondiD· 2 shared Nicolas GadotiD· 2 shared Stéphane DepiliD· 2 shared Adrian Valente· 1 shared Alexia GazeuiD· 1 shared Anne‐Claire DoffiniD· 1 shared Bertrand DuboisiD· 1 shared Christophe CauxiD· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 33 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Jenny Valladeau‐GuilemondORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Specific dendritic cells spatial organization is associated to ICB Response in Non Small Cell Lung Cancer (NSCLC)

Élisa Gobbini, Pierre Duplouye, Miguel Hurtado, Anne‐Claire Doffin, Alexia Gazeu, Léo Hermet, Martial Scavino, Justine Berthet, Léo Laoubi, Sylvie Lantuéjoul, Nicolas Gadot, Bertrand Dubois, Audrey Page, Eleonora Sosa Cuevas, Marie‐Cécile Michallet, , Jenny Valladeau‐Guilemond

The paper examines the spatial organization of dendritic cell subsets in NSCLC patients treated with anti-PD1 and finds that cDC1-driven patterns correlate with prolonged ICB response.

bioRxiv · May 7, 2026 · PreprintCancer Biology

HERV-derived epitopes represent new targets for T-cell based immunotherapies in ovarian cancer

Paola Bonaventura, Audrey Page, Olivier Tabone, Yann Estornes, Virginie Mutez, Marie Delles, Sarah Moran, Clarisse Dubois, Thibault Richard, Marjorie Lacourrège, Marie Michelas, Dina M. Tawfik, Ema Etchegaray, Adrian Valente, Rasha E. Boulos, , Stéphane Depil

This study identifies HERV-derived epitopes as potential targets for T-cell immunotherapies in ovarian cancer, showing their expression in tumors and immunogenicity in patients.

Journal for ImmunoTherapy of Cancer · Aug 1, 2025Peer-reviewedImmunology